Table of Content

1 Market Overview
1.1 Influenza Vaccines Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Influenza Vaccines Market Size & Forecast
1.4.1 Global Influenza Vaccines Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Influenza Vaccines Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Influenza Vaccines Market Drivers
1.5.2 Influenza Vaccines Market Restraints
1.5.3 Influenza Vaccines Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 AstraZeneca SWOT Analysis
2.1.3 AstraZeneca Influenza Vaccines Products and Service Offered
2.1.4 AstraZeneca Influenza Vaccines Revenue and Gross Margin
2.2 CSL
2.2.1 Business Overview
2.2.2 CSL SWOT Analysis
2.2.3 CSL Influenza Vaccines Products and Service Offered
2.2.4 CSL Influenza Vaccines Revenue and Gross Margin
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 GlaxoSmithKline SWOT Analysis
2.3.3 GlaxoSmithKline Influenza Vaccines Products and Service Offered
2.3.4 GlaxoSmithKline Influenza Vaccines Revenue and Gross Margin
2.4 Sanofi
2.4.1 Business Overview
2.4.2 Sanofi SWOT Analysis
2.4.3 Sanofi Influenza Vaccines Products and Service Offered
2.4.4 Sanofi Influenza Vaccines Revenue and Gross Margin
2.5 Altimmune
2.5.1 Business Overview
2.5.2 Altimmune SWOT Analysis
2.5.3 Altimmune Influenza Vaccines Products and Service Offered
2.5.4 Altimmune Influenza Vaccines Revenue and Gross Margin
2.6 BionVax
2.6.1 Business Overview
2.6.2 BionVax SWOT Analysis
2.6.3 BionVax Influenza Vaccines Products and Service Offered
2.6.4 BionVax Influenza Vaccines Revenue and Gross Margin
2.7 FluGen
2.7.1 Business Overview
2.7.2 FluGen SWOT Analysis
2.7.3 FluGen Influenza Vaccines Products and Service Offered
2.7.4 FluGen Influenza Vaccines Revenue and Gross Margin
2.8 FOLIA BIOTECH
2.8.1 Business Overview
2.8.2 FOLIA BIOTECH SWOT Analysis
2.8.3 FOLIA BIOTECH Influenza Vaccines Products and Service Offered
2.8.4 FOLIA BIOTECH Influenza Vaccines Revenue and Gross Margin
2.9 Genentech
2.9.1 Business Overview
2.9.2 Genentech SWOT Analysis
2.9.3 Genentech Influenza Vaccines Products and Service Offered
2.9.4 Genentech Influenza Vaccines Revenue and Gross Margin
2.10 Green Cross
2.10.1 Business Overview
2.10.2 Green Cross SWOT Analysis
2.10.3 Green Cross Influenza Vaccines Products and Service Offered
2.10.4 Green Cross Influenza Vaccines Revenue and Gross Margin
2.11 Medicago
2.11.1 Business Overview
2.11.2 Medicago SWOT Analysis
2.11.3 Medicago Influenza Vaccines Products and Service Offered
2.11.4 Medicago Influenza Vaccines Revenue and Gross Margin
2.12 Moderna Therapeutics
2.12.1 Business Overview
2.12.2 Moderna Therapeutics SWOT Analysis
2.12.3 Moderna Therapeutics Influenza Vaccines Products and Service Offered
2.12.4 Moderna Therapeutics Influenza Vaccines Revenue and Gross Margin
2.13 Novavax
2.13.1 Business Overview
2.13.2 Novavax SWOT Analysis
2.13.3 Novavax Influenza Vaccines Products and Service Offered
2.13.4 Novavax Influenza Vaccines Revenue and Gross Margin
3 Global Influenza Vaccines Market Competition, by Manufacturer
3.1 Global Influenza Vaccines Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Influenza Vaccines Players Market Share in 2023
3.2.2 Top 6 Influenza Vaccines Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Influenza Vaccines Players Head Office, Business Provided
3.4 Influenza Vaccines Mergers & Acquisitions
3.5 Influenza Vaccines New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Influenza Vaccines Revenue in Value by Type (2019-2030)
4.2 Global Influenza Vaccines Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Influenza Vaccines Revenue by Application (2019-2030)
5.2 Global Influenza Vaccines Revenue Share by Application (2019-2030)
6 Global Influenza Vaccines Market Analysis by Regions
6.1 Global Influenza Vaccines Revenue and Market Share by Regions
6.1.1 Global Influenza Vaccines Revenue by Regions (2019-2030)
6.1.2 Global Influenza Vaccines Revenue Market Share by Regions (2019-2030)
6.2 North America Influenza Vaccines Revenue and Growth (2019-2030)
6.3 Europe Influenza Vaccines Revenue and Growth (2019-2030)
6.4 Asia Pacific Influenza Vaccines Revenue and Growth (2019-2030)
6.5 South America Influenza Vaccines Revenue and Growth (2019-2030)
6.6 Middle East and Africa Influenza Vaccines Revenue and Growth (2019-2030)
7 North America Influenza Vaccines by Country, by Type, and by Application
7.1 North America Influenza Vaccines Revenue by Type (2019-2030)
7.2 North America Influenza Vaccines Revenue by Application (2019-2030)
7.3 North America Influenza Vaccines Revenue and Market Share by Countries
7.3.1 North America Influenza Vaccines Revenue in Value by Country (2019-2030)
7.3.2 United States Influenza Vaccines Revenue and Growth (2019-2030)
7.3.3 Canada Influenza Vaccines Revenue and Growth (2019-2030)
7.3.4 Mexico Influenza Vaccines Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Influenza Vaccines by Country, by Type, and by Application
8.1 Europe Influenza Vaccines Revenue by Type (2019-2030)
8.2 Europe Influenza Vaccines Revenue by Application (2019-2030)
8.3 Europe Influenza Vaccines Revenue and Market Share by Countries
8.3.1 Europe Influenza Vaccines Revenue in Value by Country (2019-2030)
8.3.2 Germany Influenza Vaccines Revenue and Growth (2019-2030)
8.3.3 France Influenza Vaccines Revenue and Growth (2019-2030)
8.3.4 United Kingdom Influenza Vaccines Revenue and Growth (2019-2030)
8.3.5 Russia Influenza Vaccines Revenue and Growth (2019-2030)
8.3.6 Italy Influenza Vaccines Revenue and Growth (2019-2030)
8.3.7 Nordic Influenza Vaccines Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Influenza Vaccines by Country, by Type, and by Application
9.1 Asia Pacific Influenza Vaccines Revenue by Type (2019-2030)
9.2 Asia Pacific Influenza Vaccines Revenue by Application (2019-2030)
9.3 Asia Pacific Influenza Vaccines Revenue and Market Share by Countries
9.3.1 Asia Pacific Influenza Vaccines Revenue in Value by Country (2019-2030)
9.3.2 China Influenza Vaccines Revenue and Growth (2019-2030)
9.3.3 Japan Influenza Vaccines Revenue and Growth (2019-2030)
9.3.4 Korea Influenza Vaccines Revenue and Growth (2019-2030)
9.3.5 India Influenza Vaccines Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Influenza Vaccines Revenue and Growth (2019-2030)
9.3.7 Australia Influenza Vaccines Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Influenza Vaccines by Country, by Type, and by Application
10.1 South America Influenza Vaccines Revenue by Type (2019-2030)
10.2 South America Influenza Vaccines Revenue by Application (2019-2030)
10.3 South America Influenza Vaccines Revenue and Market Share by Countries
10.3.1 South America Influenza Vaccines Revenue in Value by Country (2019-2030)
10.3.2 Brazil Influenza Vaccines Revenue and Growth (2019-2030)
10.3.3 Argentina Influenza Vaccines Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Influenza Vaccines by Country, by Type, and by Application
11.1 Middle East & Africa Influenza Vaccines Revenue by Type (2019-2030)
11.2 Middle East & Africa Influenza Vaccines Revenue by Application (2019-2030)
11.3 Middle East & Africa Influenza Vaccines Revenue and Market Share by Countries
11.3.1 Middle East & Africa Influenza Vaccines Revenue in Value by Country (2019-2030)
11.3.2 Turkey Influenza Vaccines Revenue and Growth (2019-2030)
11.3.3 Egypt Influenza Vaccines Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Influenza Vaccines Revenue and Growth (2019-2030)
11.3.5 UAE Influenza Vaccines Revenue and Growth (2019-2030)
11.3.6 South Africa Influenza Vaccines Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Influenza Vaccines Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Influenza Vaccines Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer